Urogen Pharma Ltd (URGN)

Operating Income Growth

100.27%

Quarterly · Period ending:

URGN logo

URGN Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported100.27%
URGN Quarterly Operating Income YoY % (-482.68% → 100.27%)
High-resolution chart · PNG

URGN operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Operating Income Growth — Quarterly
Period endingOperating Income Growth
100.2678%
45.1075%
30.888%
-56.0901%
-60.4087%
-43.411%
-89.3217%
-29.963%
-67.9821%
-16.7612%
27.9706%
25.3608%
17.8092%
-0.4008%
-1.8428%
22.837%
17.9994%
15.9187%
26.9282%
19.5165%
28.2296%
32.2787%
31.5896%
-24.1803%
-33.8778%
-71.8941%
-65.8783%
-11.2096%
-28.8543%
-64.4648%
-136.4343%
-6,860.066%
-209.7631%
-285.5285%
-173.0739%
95.0409%
-75.2872%
1.6676%
299.641%
-76.8928%
-482.6778%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.